Abingdon Health Share Discussion Threads

[buywell3] 29/3/2022 07:27

Will the poor results

Get offset by the slew of RNS's about MOU's ?

FDA approval can take years

[shallow pockets] 21/3/2022 09:11

Tick Tock.....the likes of Bigjock36 want to believe in hope but not evidence, even as whispers in the wind of takeovers and contested payments drift away. The evidence is that there is still no line of sight on any DHSC payment, even in part/at a discount. There is no product on the books that has any volume potential. Management evidences no strategy or vision other than talking about runways of opex dissipation of shareholder capital. The financials are due no later than mid week next week. Prepare to hammer the stock. Target is 4p. Any buyers of this company won't look beyond the cash at hand which is lessening each week. It's almost time for another wave to the downside, taking all longs with it.

[bigjock36] 16/3/2022 21:08

Shallow I suggest you read the Vatic update today stating they have applied for fda approval two weeks agoYou sit and stalk this board talking nonsense Anyway lets see who is right and wrong but I can see a nice rise soon My 8p buy is looking very good

[shallow pockets] 16/3/2022 15:46

Probably not ramnik007. There is probably some news out soon re the DHSC paying out something, but probably not all, of what it owes. Then what? The operating pathway gets extended but it still leads in one direction....over a cliff. Not least, the share price has only been above fair value (4p) because part of the market had priced in this payment previously. This rally is now soaking up a lot of buying and short covering and has stalled at what was previously considered an impossibly low price of 15p. The next few days will be a classic market example of selling the good news when it is announced. We are in a (long) queue to hammer this stock hard at that time all the way down to 4p as soon as the news is announced. Be ready.

[9degrees] 15/3/2022 10:03

could they work with the new owners of Omegas Alva factory

[ramnik007] 15/3/2022 09:23

Perhaps Avacta and Abdx have found a way to produce Affimer based, and more accurate LFT. Interesting both rising in synch!

[bigjock36] 14/3/2022 21:21

Shallow pockets you are incorrect Vatic TT is due in March with orders They only recently tweeted this is still on trackClose your short I repeat close your short

[glasswala] 14/3/2022 14:55

A fundraise no doubt to mug the punters once again. This is time tested method by mms to lull people to buy in and then slam in a fundraise and then dropping it like stone in a deep well.Talk about corruption and lining your own grubby pockets the Brits made up the phrase so must be master of it.

[mick1909] 14/3/2022 12:43

Dead cat bounce

[ramnik007] 14/3/2022 12:34

Insiders know something

[megsta] 14/3/2022 12:33

Why is the price increasing?

[innit2] 14/3/2022 10:54

tick tock? up 35% in two trading days, shivers

[bigjock36] 11/3/2022 17:44

Shallow i look forward to TT completing this month for Vatic and your short burning

[shallow pockets] 11/3/2022 09:11

Tick Tock. Tick Tock....can you hear it? It's every minute that passes as management desperately waits to secure the hoped for overdue payment from the DHSC. Financial accounts are due this month. Without any payment, we expect the share price to hit the 4p level. Should a miracle occur, and the DHSC payout happen, even if it is only in part, any share price bounce is to be sold hard. We cannot discover any plan or products or customers of this company that are going to generate any net revenues that turn it from a constant loss maker to profitable or even breakeven. So the current pathway of capital burn and any extension of it funded by the DHSC still leads in only one direction......straight over the cliff edge into the gorge below.. Prepare to reinstate shorts if given the wonderful chance above 12p

[shallow pockets] 08/3/2022 18:07

No dennisbergkamp, it's not about bias. It's about the objective of price efficiency. I am not a "shorter". I am just as happy to be long. But I call it as I see it. Value is the target. Higher or lower. And in this case...its lower still.

[dennisbergkamp] 08/3/2022 17:53

You shorters literally kill lively-hoods, the worse kind of vulture

D

[shallow pockets] 08/3/2022 17:34

We are now more and more stuck BELOW our original target of 8p. We are moving to the sidelines on tonight's close, probably only temporarily , before seeking to reinstate a short with a new target of 3p which we think is fair value and that's IF they get monies owed to them from the Government. If they don't, we think the company goes under. In any event, new top level management is urgently required to build new products and new customers to generate more solid revenues. No matter what the upbeat message from the company later this month, this company has the mark of death written all over it tonight.

[andymunchkin] 03/3/2022 09:31

Average down mug6 Oct '21 - 10:23 - 758 of 1344
0 0 0
48.9 to buy now 🚀🚀🚀🚀8640;🚀Ԇ40;
———;—-
AveraGeDoon cnT😂😂;😂

[amanitaangelicus] 03/3/2022 09:26

A slow death ...due to its key partners not sticking to deadlines. Tragic.

[shallow pockets] 02/3/2022 09:37

This morning our target of 8p got hit. We are NOT covering our shorts just yet. There is more price downside here, as cash drains daily, no investors are in sight, and the next secular phase of medical/health testing is 6 months or more away. Management seem devoid of ideas or a strategy and no one is accepting responsibility for this share price destruction. Viewing a contested Government debt as an asset could even appear delusional, especially with this Government. Stay short.

[dennisbergkamp] 02/3/2022 09:34

that was your 8p share price

Thinking about averaging massively down, but will see what further reaction therre is to the news

D

[shallow pockets] 23/2/2022 16:46

The share price is bouncing today within a trend of lower lows and lower highs. Today's small bounce is NOT noteworthy as today's volume is so low, and thus probably a bounce instigated by the broker. My informants tell me that there is a growing air of desperation within the company and its senior management which own the majority of the stock. Furthermore, there is no apparent interest to invest nor acquire from external players at this time, contrary to the forlorn needs and hopes of Gruen above. The market has taken the view that this company is in as much trouble as Omega. As each day passes, and sticker price shock diminishes, what once looked cheap (e.g 25p) now would be grasped with both hands by incumbent shareholders. Stay short. Target 8p.